Allergen, Individual-Micro organism Candida Albicans fungus M5

The Allergen, Individual–Micro organism Candida Albicans fungus M5 is a discreet home collection test designed to detect the presence of Candida albicans, the common yeast responsible for vulvovaginal candidiasis, oral thrush and other mucocutaneous fungal infections. The sample (typically a self-collected swab from the affected site) is analysed in an accredited laboratory using sensitive methods such as culture and/or molecular (PCR) testing to confirm organism presence and load. Accurate identification of C. albicans helps clinicians distinguish yeast infections from bacterial or protozoal causes and guides appropriate antifungal therapy.

This test is suitable for individuals experiencing symptoms such as itching, abnormal discharge, burning during urination, or recurrent episodes of suspected yeast infection, and for those with risk factors like recent antibiotic use, diabetes, or immunosuppression. Results are delivered securely across Dubai and the UAE with confidential electronic reporting, enabling prompt clinical follow-up and targeted treatment recommendations from your healthcare provider.

Preparation is simple but important: avoid douching, intravaginal creams, or sexual intercourse for 24–48 hours before sample collection and refrain from topical or oral antifungal agents for at least 72 hours if clinically safe to do so. Typical laboratory turnaround is within 24–72 hours depending on the assay, and a positive result may be accompanied by organism quantification or antifungal susceptibility if requested—consult with a physician in Dubai for interpretation and prescription guidance.

• Candida albicans — Presence / Absence
• Quantitative fungal load (CFU/ml or semi-quantitative)
• Organism identification (culture/PCR confirmation)
• Antifungal susceptibility profile (where performed)

• Persistent or recurrent itching and irritation of genital or oral mucosa
• Abnormal, cottage-cheese–like genital discharge
• Burning sensation during urination or painful intercourse
• Following prolonged antibiotic therapy or immunosuppression
• Unresolved symptoms after empiric treatment or for targeted therapy selection

• Discreet at‑home sample collection with professional laboratory analysis
• Accurate identification of C. albicans to guide appropriate antifungal treatment
• Fast laboratory turnaround and secure electronic reporting across Dubai/UAE
• Reduces need for immediate clinic visit and supports confidential sexual health screening
• Optional susceptibility testing to assist targeted therapy when required

• At‑home or supervised swab collection from the affected site (vaginal, oral, or urethral as appropriate)
• Avoid intravaginal products, douching, and sexual intercourse for 24–48 hours prior to collection
• Do not use topical or oral antifungal medications for at least 72 hours before sampling, if clinically permissible
• Suitable for adults and adolescents; consult a clinician for testing in children or pregnant individuals